propranolol has been researched along with Rosacea in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxycycline is the standard systemic treatment for rosacea." | 6.80 | Propranolol, doxycycline and combination therapy for the treatment of rosacea. ( Kim, BS; Kim, HS; Kim, MB; Ko, HC; Mun, JH; Park, JM; Song, M, 2015) |
| "Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause." | 5.33 | Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. ( Cohen, JB; Craige, H, 2005) |
| "Doxycycline is the standard systemic treatment for rosacea." | 2.80 | Propranolol, doxycycline and combination therapy for the treatment of rosacea. ( Kim, BS; Kim, HS; Kim, MB; Ko, HC; Mun, JH; Park, JM; Song, M, 2015) |
| "Rosacea is a chronic skin disease of unknown etiology, affecting the central areas of the face skin (cheeks, chin, nose, forehead) and is characterized by periods of remission and exacerbation." | 2.78 | [New possibilities in the treatment of early stages of rosacea]. ( Katsitadze, A; Tsiskarishvili, NV; Tsiskarishvili, Ts, 2013) |
| "Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
| "Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause." | 1.33 | Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. ( Cohen, JB; Craige, H, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Logger, JGM | 1 |
| Olydam, JI | 1 |
| Driessen, RJB | 1 |
| Park, JM | 1 |
| Mun, JH | 1 |
| Song, M | 1 |
| Kim, HS | 1 |
| Kim, BS | 1 |
| Kim, MB | 1 |
| Ko, HC | 1 |
| Kwon, HJ | 1 |
| Suh, JH | 1 |
| Ko, EJ | 1 |
| Kim, BJ | 1 |
| Kosmidou, M | 1 |
| Gaitanis, G | 1 |
| Nomikos, K | 1 |
| Zioga, A | 1 |
| Katsanos, K | 1 |
| Bassukas, ID | 1 |
| Tsianos, E | 1 |
| Tsiskarishvili, NV | 1 |
| Katsitadze, A | 1 |
| Tsiskarishvili, Ts | 1 |
| Craige, H | 1 |
| Cohen, JB | 1 |
1 review available for propranolol and Rosacea
| Article | Year |
|---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
2 trials available for propranolol and Rosacea
| Article | Year |
|---|---|
Propranolol, doxycycline and combination therapy for the treatment of rosacea.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combinat | 2015 |
[New possibilities in the treatment of early stages of rosacea].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Anti-Bacterial Agents; Erythema; Female | 2013 |
3 other studies available for propranolol and Rosacea
| Article | Year |
|---|---|
Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea.
Topics: Adult; Anti-Bacterial Agents; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Minocy | 2017 |
Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Biopsy; Colitis, Ulcerative; Dermatologic Agents; | 2009 |
Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Flushing; Humans; Male; Middle Aged; Propranolol; | 2005 |